Second cancers in survivors of childhood cancer (Q35084794)

6 August 2017

1 reference

title

Second cancers in survivors of childhood cancer (English)

1 reference

6 August 2017

1 reference

Smita Bhatia

1 reference

6 August 2017

Charles Sklar

series ordinal

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

6 August 2017

published in

Nature Reviews Cancer

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

124-132

1 reference

Breast cancer and other second neoplasms after childhood Hodgkin's disease

6 August 2017

cites work

1 reference

Second neoplasms after acute lymphoblastic leukemia in childhood.

21 January 2018

1 reference

Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

21 January 2018

1 reference

Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries

21 January 2018

1 reference

Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group

21 January 2018

1 reference

Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer

21 January 2018

1 reference

Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries

21 January 2018

1 reference

Breast cancer after treatment of Hodgkin's disease.

21 January 2018

1 reference

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

21 January 2018

1 reference

Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's Lymphoma

21 January 2018

1 reference

Second cancers following pediatric Hodgkin's disease

21 January 2018

1 reference

Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of

21 January 2018

1 reference

Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group

21 January 2018

1 reference

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

21 January 2018

1 reference

Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer

21 January 2018

1 reference

When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs

21 January 2018

1 reference

Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors

21 January 2018

1 reference

Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints

21 January 2018

1 reference

Multiple primary cancers in families with Li-Fraumeni syndrome

21 January 2018

1 reference

Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease

21 January 2018

1 reference

Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history

21 January 2018

1 reference

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

21 January 2018

1 reference

Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect

21 January 2018

1 reference

Association of CYP3A4 genotype with treatment-related leukemia

21 January 2018

1 reference

The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance

21 January 2018

1 reference

Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review

21 January 2018

1 reference

The human hepatic cytochromes P450 involved in drug metabolism

21 January 2018

1 reference

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

21 January 2018

1 reference

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

21 January 2018

1 reference

Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre

21 January 2018

1 reference

Radiotherapy-induced lung cancer among women who smoke.

21 January 2018

1 reference

Interaction of alcohol and tobacco in laryngeal cancer.

21 January 2018

1 reference

The role of alcohol in oesophageal cancer in non-smokers, and of tobacco in non-drinkers.

21 January 2018

1 reference

Environment and Cancer: Who Are Susceptible?

21 January 2018

1 reference

Endogenous estrogen and postmenopausal breast cancer: a quantitative review

21 January 2018

1 reference

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

21 January 2018

1 reference

Role of the insulin-like growth factor family in cancer development and progression

21 January 2018

1 reference

Growth and neuroendocrine dysfunction following therapy for childhood cancer

21 January 2018

1 reference

Risk factors for breast cancer in women under 40 years.

21 January 2018

1 reference

Guidelines for healthy weight

21 January 2018

1 reference

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

21 January 2018

1 reference

Radiation-induced skin carcinomas of the head and neck.

31 March 2020

1 reference

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

31 March 2020

1 reference

Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk

31 March 2020

1 reference

Risk of subsequent malignant neoplasms among 470,000 cancer patients in Finland, 1953-1991

31 March 2020

1 reference

Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996

31 March 2020

1 reference

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

31 March 2020

1 reference

Differences in lung cancer risk between men and women: examination of the evidence

31 March 2020

1 reference

Bone sarcomas linked to radiotherapy and chemotherapy in children

31 March 2020

1 reference

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence

31 March 2020

1 reference

Breast masses in women treated for childhood cancer: incidence and screening guidelines

31 March 2020

1 reference

Thyroid carcinomas after irradiation for a first cancer during childhood

31 March 2020

1 reference

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment

31 March 2020

1 reference

Leukemia after therapy with alkylating agents for childhood cancer

31 March 2020

1 reference

Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide

31 March 2020

1 reference

Secondary leukemias induced by topoisomerase-targeted drugs

31 March 2020

1 reference

Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints

31 March 2020

1 reference

Secondary acute non-lymphoblastic leukemia in two children following treatment with a cis-diamminedichloroplatinum-II-based regimen for osteosarcoma

31 March 2020

1 reference

Incidence of cancer in 161 families affected by ataxia-telangiectasia

31 March 2020

1 reference

Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor

31 March 2020

1 reference

Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia

31 March 2020

1 reference

Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalities

31 March 2020

1 reference

Smoking, treatment for Hodgkin's disease, and subsequent lung cancer risk

31 March 2020

1 reference

Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers

31 March 2020

1 reference

The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx

31 March 2020

1 reference

Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation

31 March 2020

1 reference

Endocrine complications of pediatric stem cell transplantation.

31 March 2020

1 reference

High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC722

1 reference

6 August 2017

1 reference